Peterson Kristine has filed 7 insider transactions across 3 companies since March 2024.
Most recent transaction: a grant/award of 20000 shares of ENANTA PHARMACEUTICALS INC ($ENTA) on March 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Peterson Kristine | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 29,019,344 | 9999.99% | 0.07% |
| June 18, 2025 | ArriVent BioPharma, Inc. | $AVBP | Peterson Kristine | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| May 15, 2025 | Immunocore Holdings plc | $IMCR | Peterson Kristine | Not found | A | Share Option (Right to Buy) | 26198 | $0.00 | 26,198.0000 | 49,991,064 | 9999.99% | 0.05% |
| March 13, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Peterson Kristine | Director | A | Stock Option (right to buy) | 15700 | $0.00 | 15,700.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | Immunocore Holdings plc | $IMCR | Peterson Kristine | Not found | A | Share Option (Right to Buy) | 14534 | $0.00 | 14,534.0000 | 48,888,975 | 9999.99% | 0.03% |
| April 22, 2024 | ArriVent BioPharma, Inc. | $AVBP | Peterson Kristine | Director | A | Stock Option (right to buy) | 28587 | $0.00 | 28,587.0000 | 25,046,531 | 9999.99% | 0.11% |
| March 6, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Peterson Kristine | Director | A | Stock Option (right to buy) | 15700 | $0.00 | 15,700.0000 | 0 | 9999.99% | 0.00% |